Wednesday, July 30, 2014 Last update: 2:03 AM
FreshNews.com - All Company Technology News Since 1996

VIVUS, Inc.

News articles for VIVUS, Inc.:

Thursday, June 12, 2014

  • VIVUS Files Lawsuit Against Actavis for Infringement of Qsymia Patents
    MOUNTAIN VIEW, CA--(Marketwired - June 12, 2014) - VIVUS, Inc. (NASDAQ: VVUS) today announced that it has filed a lawsuit in the U.S. District Court for the District of New Jersey against Actavis Laboratories FL, Inc., Actavis, Inc., and Actavis PLC, collectively referred to ... read more
  • VIVUS to Present at Upcoming Investor Conference
    MOUNTAIN VIEW, CA--(Marketwired - June 12, 2014) - VIVUS, Inc. (NASDAQ: VVUS) today announced that management will present an overview of the company at the following investor conference:2014 Wells Fargo Healthcare Conference June 17, 2014, 8:15am EDT InterContinental Hotel, BostonA live webcast and 30-day ... read more

Monday, May 19, 2014

Thursday, May 15, 2014

Thursday, May 8, 2014

Monday, May 5, 2014

  • VIVUS Reports First Quarter 2014 Financial Results
    MOUNTAIN VIEW, CA--(Marketwired - May 05, 2014) - VIVUS, Inc. (NASDAQ: VVUS), a biopharmaceutical company commercializing Qsymia® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today reported its financial results for the first quarter ... read more

Friday, April 11, 2014

Tuesday, April 8, 2014

Thursday, April 3, 2014

Tuesday, March 25, 2014

Wednesday, March 19, 2014